KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Debt Ratio (2016 - 2026)

Bio-Rad Laboratories has reported Debt Ratio over the past 18 years, most recently at 0.08 for Q1 2026.

  • Quarterly Debt Ratio fell 97.9% to 0.08 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.08 through Mar 2026, down 97.9% year-over-year, with the annual reading at 0.11 for FY2025, 11.37% down from the prior year.
  • Debt Ratio was 0.08 for Q1 2026 at Bio-Rad Laboratories, down from 0.11 in the prior quarter.
  • Over five years, Debt Ratio peaked at 3997.0 in Q4 2023 and troughed at 0.08 in Q1 2026.
  • The 5-year median for Debt Ratio is 0.11 (2025), against an average of 400.16.
  • Year-over-year, Debt Ratio skyrocketed 3943302.66% in 2022 and then plummeted 100.0% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 1996.19 in 2022, then soared by 100.23% to 3997.0 in 2023, then plummeted by 100.0% to 0.13 in 2024, then decreased by 11.37% to 0.11 in 2025, then decreased by 27.82% to 0.08 in 2026.
  • Per Business Quant, the three most recent readings for BIO's Debt Ratio are 0.08 (Q1 2026), 0.11 (Q4 2025), and 0.12 (Q3 2025).